Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Oxysterols receptor LXR-beta |
---|
Ligand | BDBM114863 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based screening assay to identify agonists of the Liver-X-Receptor (LXR). |
---|
IC50 | 67502±n/a nM |
---|
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based screening assay to identify agonists of the Liver-X-Receptor (LXR). PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Oxysterols receptor LXR-beta |
---|
Name: | Oxysterols receptor LXR-beta |
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 50978.79 |
Organism: | Homo sapiens (Human) |
Description: | P55055 |
Residue: | 460 |
Sequence: | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQ
SQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKR
SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI
ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR
RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM
LMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
|
|
BDBM114863 |
---|
n/a |
---|
Name | BDBM114863 |
Synonyms: | MLS000334398 | N-[3-[4-bromo-3-(trifluoromethyl)anilino]-3-keto-propyl]-2-chloro-benzamide | N-[3-[4-bromo-3-(trifluoromethyl)anilino]-3-oxopropyl]-2-chlorobenzamide | N-[3-[[4-bromanyl-3-(trifluoromethyl)phenyl]amino]-3-oxidanylidene-propyl]-2-chloranyl-benzamide | SMR000249156 | cid_2481997 |
Type | Small organic molecule |
Emp. Form. | C17H13BrClF3N2O2 |
Mol. Mass. | 449.65 |
SMILES | FC(F)(F)c1cc(NC(=O)CCNC(=O)c2ccccc2Cl)ccc1Br |
Structure |
|